Literature DB >> 23397607

Reply to “Response to “CD20 positive cells are undetectable in the majority of multiple myeloma cell lines and are not associated with a cancer stem cell phenotype”. Haematologica 2012;97(7):1110-1114.

Teresa Paíno, Bruno Paiva, Jesús San Miguel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23397607      PMCID： PMC3533679          DOI： 10.3324/haematol.2012.077727

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  11 in total

1.  Prognostic value of circulating plasma cells in monoclonal gammopathy of undetermined significance.

Authors:  Shaji Kumar; S Vincent Rajkumar; Robert A Kyle; Martha Q Lacy; Angela Dispenzieri; Rafael Fonseca; John A Lust; Morie A Gertz; Philip R Greipp; Thomas E Witzig
Journal:  J Clin Oncol       Date:  2005-08-20       Impact factor: 44.544

2.  CD20 positive cells are undetectable in the majority of multiple myeloma cell lines and are not associated with a cancer stem cell phenotype.

Authors:  Teresa Paíno; Enrique M Ocio; Bruno Paiva; Laura San-Segundo; Mercedes Garayoa; Norma C Gutiérrez; M Eugenia Sarasquete; Atanasio Pandiella; Alberto Orfao; Jesús F San Miguel
Journal:  Haematologica       Date:  2012-02-07       Impact factor: 9.941

3.  Circulating plasma cells detected by flow cytometry as a predictor of survival in 302 patients with newly diagnosed multiple myeloma.

Authors:  Grzegorz S Nowakowski; Thomas E Witzig; David Dingli; Michal J Tracz; Morie A Gertz; Martha Q Lacy; John A Lust; Angela Dispenzieri; Philip R Greipp; Robert A Kyle; S Vincent Rajkumar
Journal:  Blood       Date:  2005-06-16       Impact factor: 22.113

4.  Circulating human B and plasma cells. Age-associated changes in counts and detailed characterization of circulating normal CD138- and CD138+ plasma cells.

Authors:  Anouk Caraux; Bernard Klein; Bruno Paiva; Caroline Bret; Alexander Schmitz; Gwenny M Fuhler; Nico A Bos; Hans E Johnsen; Alberto Orfao; Martin Perez-Andres
Journal:  Haematologica       Date:  2010-01-15       Impact factor: 9.941

5.  Can multiple myeloma become a curable disease?

Authors:  Jesús F San-Miguel; María-Victoria Mateos
Journal:  Haematologica       Date:  2011-09       Impact factor: 9.941

6.  Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells.

Authors:  Piyush B Gupta; Christine M Fillmore; Guozhi Jiang; Sagi D Shapira; Kai Tao; Charlotte Kuperwasser; Eric S Lander
Journal:  Cell       Date:  2011-08-19       Impact factor: 41.582

7.  Competition between clonal plasma cells and normal cells for potentially overlapping bone marrow niches is associated with a progressively altered cellular distribution in MGUS vs myeloma.

Authors:  B Paiva; M Pérez-Andrés; M-B Vídriales; J Almeida; N de las Heras; M-V Mateos; L López-Corral; N C Gutiérrez; J Blanco; A Oriol; M T Hernández; F de Arriba; A G de Coca; M-J Terol; J de la Rubia; Y González; A Martín; A Sureda; M Schmidt-Hieber; A Schmitz; H E Johnsen; J-J Lahuerta; J Bladé; J F San-Miguel; A Orfao
Journal:  Leukemia       Date:  2011-01-21       Impact factor: 11.528

8.  Circulating monoclonal B cells expressing P glycoprotein may be a reservoir of multidrug-resistant disease in multiple myeloma.

Authors:  L M Pilarski; A R Belch
Journal:  Blood       Date:  1994-02-01       Impact factor: 22.113

9.  Characterization of clonogenic multiple myeloma cells.

Authors:  William Matsui; Carol Ann Huff; Qiuju Wang; Matthew T Malehorn; James Barber; Yvette Tanhehco; B Douglas Smith; Curt I Civin; Richard J Jones
Journal:  Blood       Date:  2003-11-20       Impact factor: 22.113

10.  High levels of peripheral blood circulating plasma cells as a specific risk factor for progression of smoldering multiple myeloma.

Authors:  G Bianchi; R A Kyle; D R Larson; T E Witzig; S Kumar; A Dispenzieri; W G Morice; S V Rajkumar
Journal:  Leukemia       Date:  2012-08-20       Impact factor: 11.528
View more
  1 in total

1.  Phenotypic, genomic and functional characterization reveals no differences between CD138++ and CD138low subpopulations in multiple myeloma cell lines.

Authors:  Teresa Paíno; María E Sarasquete; Bruno Paiva; Patryk Krzeminski; Laura San-Segundo; Luis A Corchete; Alba Redondo; Mercedes Garayoa; Ramón García-Sanz; Norma C Gutiérrez; Enrique M Ocio; Jesús F San-Miguel
Journal:  PLoS One       Date:  2014-03-21       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.